Warren J. Leonard
23Patents
8h-index
31Co-inventors
75Inventor score
Filing activity: Apr 19, 1985 → May 26, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7378276B2 | Method of inducing memory B cell development and terminal differentiation | Physics | 33 | Expired |
| US7731953B2 | Methods for use of TSLP and agonists and antagonists thereof | Human Necessities | 21 | Active |
| US6265160A | Method of identifying inhibitors of the Jak-Stat signal transduction pathway | Human Necessities | 20 | Expired |
| US4707443A | Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same | Emerging Cross-Sectional Technologies | 18 | Expired |
| US10150802B2 | Superagonists, partial agonists and antagonists of interleukin-2 | Chemistry; Metallurgy | 16 | Active |
| US5356795A | Cloning cDNAs for the human interleukin-2 receptor (55 RD protein) | Chemistry; Metallurgy | 15 | Expired |
| US8247228B2 | Method of inducing memory B cell development and terminal differentiation | Physics | 11 | Active |
| US7070972B1 | Janus family kinases and identification of immune modulators | Human Necessities | 9 | Expired |
| US6955895B2 | Thymic stromal lymphopoietin receptor molecules and uses thereof | Chemistry; Metallurgy | 5 | Expired |
| US5912173A | Transgenic murine model for XSCID | Chemistry; Metallurgy | 4 | Expired |
| US10654905B2 | Method of treating graft versus host disease with an interleukin-2 mutein | Chemistry; Metallurgy | 2 | Active |
| US5518880A | Methods for diagnosis of XSCID and kits thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US4935367A | Novel restriction endonuclease | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11384131B2 | Superagonists, partial agonists and antagonists of interleukin-2 | Chemistry; Metallurgy | 1 | Active |
| US7993919B2 | Method of inducing memory B cell development and terminal differentiation | Physics | 1 | Expired |
| US5073486A | Assay for Mycoplasma fermentans | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10201591B2 | TSLP induces neutrophil mediated killing of methicillin-resistant staphylococcus aureus | Human Necessities | 0 | Active |
| US7332645B2 | IL-21 as a regulator of immunoglobin production | Human Necessities | 0 | Expired |
| US7488808B2 | Janus family kinases and identification of immune modulators | Human Necessities | 0 | Expired |
| US7902348B2 | Janus family kinases and identification of immune modulators | Human Necessities | 0 | Active |
| US12202873B2 | Superagonists, partial agonists and antagonists of interleukin-2 | Chemistry; Metallurgy | 0 | Active |
| US5833983A | Interleukin 2 receptor and applications thereof | Chemistry; Metallurgy | 0 | Expired |
| US7402659B2 | Thymic stromal lymphopoietin receptor molecules and uses thereof | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.